annual current liabilities:
$200.75M+$22.84M(+12.84%)Summary
- As of today (July 1, 2025), TVTX annual total current liabilities is $200.75 million, with the most recent change of +$22.84 million (+12.84%) on December 31, 2024.
- During the last 3 years, TVTX annual current liabilities has risen by +$76.66 million (+61.78%).
- TVTX annual current liabilities is now at all-time high.
Performance
TVTX Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$182.46M-$18.29M(-9.11%)Summary
- As of today (July 1, 2025), TVTX quarterly total current liabilities is $182.46 million, with the most recent change of -$18.29 million (-9.11%) on March 31, 2025.
- Over the past year, TVTX quarterly current liabilities has increased by +$9.23 million (+5.33%).
- TVTX quarterly current liabilities is now -9.11% below its all-time high of $200.75 million, reached on December 31, 2024.
Performance
TVTX quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TVTX Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.8% | +5.3% |
| 3 y3 years | +61.8% | +52.7% |
| 5 y5 years | +110.3% | +168.0% |
TVTX Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +61.8% | -9.1% | +50.5% |
| 5 y | 5-year | at high | +116.7% | -9.1% | +160.9% |
| alltime | all time | at high | >+9999.0% | -9.1% | >+9999.0% |
TVTX Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $182.46M(-9.1%) |
| Dec 2024 | $200.75M(+12.8%) | $200.75M(+5.6%) |
| Sep 2024 | - | $190.04M(+56.7%) |
| Jun 2024 | - | $121.27M(-30.0%) |
| Mar 2024 | - | $173.23M(-2.6%) |
| Dec 2023 | $177.91M(+25.1%) | $177.91M(+27.6%) |
| Sep 2023 | - | $139.43M(+2.7%) |
| Jun 2023 | - | $135.71M(+3.9%) |
| Mar 2023 | - | $130.65M(-8.1%) |
| Dec 2022 | $142.16M(+14.6%) | $142.16M(+8.5%) |
| Sep 2022 | - | $131.03M(+5.3%) |
| Jun 2022 | - | $124.49M(+4.2%) |
| Mar 2022 | - | $119.47M(-3.7%) |
| Dec 2021 | $124.09M(+33.9%) | $124.09M(+9.7%) |
| Sep 2021 | - | $113.16M(+16.7%) |
| Jun 2021 | - | $96.98M(+14.1%) |
| Mar 2021 | - | $85.01M(-8.3%) |
| Dec 2020 | $92.66M(-2.9%) | $92.66M(+22.8%) |
| Sep 2020 | - | $75.43M(+7.9%) |
| Jun 2020 | - | $69.93M(+2.7%) |
| Mar 2020 | - | $68.09M(-28.7%) |
| Dec 2019 | $95.45M(-8.8%) | $95.45M(+8.4%) |
| Sep 2019 | - | $88.02M(-2.8%) |
| Jun 2019 | - | $90.59M(-13.0%) |
| Mar 2019 | - | $104.08M(-0.5%) |
| Dec 2018 | $104.62M(+22.1%) | $104.62M(+4.8%) |
| Sep 2018 | - | $99.87M(-3.5%) |
| Jun 2018 | - | $103.50M(+83.1%) |
| Mar 2018 | - | $56.52M(-34.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $85.67M(+2.9%) | $85.67M(+2.1%) |
| Sep 2017 | - | $83.90M(+5.4%) |
| Jun 2017 | - | $79.63M(+4.0%) |
| Mar 2017 | - | $76.56M(-8.1%) |
| Dec 2016 | $83.26M(-4.3%) | $83.26M(-3.2%) |
| Sep 2016 | - | $85.99M(+7.4%) |
| Jun 2016 | - | $80.07M(+20.2%) |
| Mar 2016 | - | $66.62M(-23.4%) |
| Dec 2015 | $86.98M(-19.1%) | $86.98M(-14.7%) |
| Sep 2015 | - | $101.95M(-40.9%) |
| Jun 2015 | - | $172.38M(+68.7%) |
| Mar 2015 | - | $102.17M(-5.0%) |
| Dec 2014 | $107.54M(+194.1%) | $107.54M(+118.9%) |
| Sep 2014 | - | $49.13M(+2.4%) |
| Jun 2014 | - | $47.98M(-57.7%) |
| Mar 2014 | - | $113.45M(+210.3%) |
| Dec 2013 | $36.56M(+530.5%) | $36.56M(+34.6%) |
| Sep 2013 | - | $27.17M(+144.1%) |
| Jun 2013 | - | $11.13M(+816.0%) |
| Mar 2013 | - | $1.22M(+1668.6%) |
| Dec 2012 | $5.80M(+8555.4%) | - |
| Nov 2012 | - | $68.70K(+1.0%) |
| Aug 2012 | - | $68.00K(+0.7%) |
| May 2012 | - | $67.50K(+0.7%) |
| Feb 2012 | - | $67.00K(+2.0%) |
| Feb 2012 | $67.00K(+4.4%) | - |
| Nov 2011 | - | $65.70K(+63.4%) |
| Aug 2011 | - | $40.20K(-37.4%) |
| Feb 2011 | $64.20K | $64.20K |
FAQ
- What is Travere Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Travere Therapeutics?
- What is Travere Therapeutics annual current liabilities year-on-year change?
- What is Travere Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Travere Therapeutics?
- What is Travere Therapeutics quarterly current liabilities year-on-year change?
What is Travere Therapeutics annual total current liabilities?
The current annual current liabilities of TVTX is $200.75M
What is the all time high annual current liabilities for Travere Therapeutics?
Travere Therapeutics all-time high annual total current liabilities is $200.75M
What is Travere Therapeutics annual current liabilities year-on-year change?
Over the past year, TVTX annual total current liabilities has changed by +$22.84M (+12.84%)
What is Travere Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of TVTX is $182.46M
What is the all time high quarterly current liabilities for Travere Therapeutics?
Travere Therapeutics all-time high quarterly total current liabilities is $200.75M
What is Travere Therapeutics quarterly current liabilities year-on-year change?
Over the past year, TVTX quarterly total current liabilities has changed by +$9.23M (+5.33%)